Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesEarly Prediction of Response to First-Line Therapy Using Integrated 18F-FDG PET/CT for Patients with Advanced/Metastatic Non-small Cell Lung Cancer
Journal of Thoracic Oncology, 06/29/09
Lee DH et al. - Single 18-fluorodeoxyglucose positron emission tomography/computed tomography scan taken after one cycle of treatment could predict progressive disease earlier than standard radiographic evaluation and can be used as a measure to avoid ineffective systemic chemotherapy.
Today in Diagnostic/Lung Function...keeping you current
Receive free subspecialty "5-minute updates" via email
Pulmonary function testing in young children
Paediatric Respiratory Reviews, 11/04/09
Novel Influenza A(H1N1): Clinical Presentation, Diagnosis, and Management
Pediatric Emergency Care, 11/16/09
Newer diagnostic techniques for tuberculosis
Respiratory Medicine CME, 11/24/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer
Journal of Clinical Oncology, 10/29/09
New Advances in the Second-Line Treatment of Small Cell Lung Cancer
The Oncologist, 10/28/09
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer
Journal of Clinical Oncology, 11/05/09
Sponsor
Article Search
Sponsor